choroidal nevus: Definition, Uses, and Clinical Overview

Posted on February 27, 2026 | by dreye

choroidal nevus Introduction (What it is)

A choroidal nevus is a typically benign (non-cancerous) pigmented spot inside the eye.
It forms in the choroid, a vascular layer beneath the retina.
Many people have no symptoms, and it is often found during a routine dilated eye exam.
In eye care, it is commonly discussed as a finding that may need documentation and monitoring over time.

Why choroidal nevus used (Purpose / benefits)

A choroidal nevus is not a treatment or a device—it is a clinical diagnosis describing a specific type of intraocular lesion. The “use” of the term is to identify, document, and communicate what clinicians see in the back of the eye, and to guide appropriate follow-up.

Key purposes and benefits of recognizing a choroidal nevus include:

Accurate description of a common finding: It provides a clear label for a melanocytic (pigment-related) lesion in the choroid that is often benign.
Baseline documentation for future comparison: Recording size, location, and appearance helps clinicians detect meaningful change over time.
Risk-based monitoring: Some lesions have features that raise concern for growth or malignancy; identification helps determine whether closer surveillance is appropriate.
Differentiation from more serious conditions: A main clinical goal is distinguishing a benign nevus from conditions that may require urgent evaluation, such as choroidal melanoma (a malignant tumor) or other retinal/choroidal abnormalities.
Explaining patient symptoms when present: While many nevi are asymptomatic, certain associated findings (such as subretinal fluid) may correlate with visual symptoms and influence evaluation.

Indications (When ophthalmologists or optometrists use it)

Clinicians consider and document a choroidal nevus in situations such as:

A pigmented or non-pigmented lesion is seen on dilated fundus examination.
An incidental finding during routine eye exams (including diabetic or general retinal screening).
Evaluation of symptoms like blurred vision, distortion (metamorphopsia), or new floaters, when the posterior segment is examined.
Monitoring a previously known lesion to assess for stability or growth.
When imaging is ordered to better characterize the lesion, such as ocular ultrasound, optical coherence tomography (OCT), or fundus photography.
Referral scenarios where a primary eye care clinician requests a retinal specialist’s opinion to confirm diagnosis or risk stratify.

Contraindications / when it’s NOT ideal

Because choroidal nevus is a diagnostic label rather than a therapy, “contraindications” mainly refer to times when the label is not appropriate or when a different diagnostic approach is needed.

Situations where calling a lesion a choroidal nevus may be not ideal, or when another approach may be preferred, include:

Suspicion for malignancy: If features suggest choroidal melanoma or another tumor, clinicians may avoid reassurance and instead pursue specialized evaluation. The correct label may change as more information is gathered.
Inadequate view of the retina/choroid: Dense cataract, corneal opacity, or vitreous hemorrhage can limit visualization; diagnosis may be deferred until imaging or a clearer view is possible.
Atypical appearance: Lesions that do not match common nevus patterns (for example, unusual color, shape, associated bleeding, or extensive fluid) may require broader differential diagnosis.
Alternative diagnoses are more likely: Some findings can mimic a nevus (e.g., congenital retinal pigment epithelium lesions, inflammatory scars, vascular tumors, or metastatic disease). Additional testing may be more appropriate than assigning the nevus label.
Rapid change by history or records: If documented growth is seen over a short interval, clinicians may prioritize urgent assessment to rule out malignant transformation or a different underlying condition.

How it works (Mechanism / physiology)

A choroidal nevus represents a localized accumulation of melanocytes (pigment-producing cells) within the choroid, which lies between the retina and the sclera (the white outer wall of the eye). The choroid is rich in blood vessels and supports the outer retina.

High-level physiology and anatomy to know:

Choroid: A vascular layer supplying oxygen and nutrients to retinal tissues. Lesions in this layer can sometimes influence the overlying retina.
Retina: The light-sensing tissue lining the inside of the eye. A nevus itself is beneath the retina, but secondary effects (like fluid) can affect vision.
Retinal pigment epithelium (RPE): A thin pigmented layer that supports photoreceptors. Long-standing choroidal lesions may be associated with RPE changes such as drusen (small deposits) or pigment alterations.

What a choroidal nevus does (and does not do):

It does not “work” like a medication or procedure. There is no onset, duration, or reversibility in the typical therapeutic sense.
It is generally stable, but clinicians monitor it because some lesions can change. Change may involve growth, new fluid under the retina, or other features that shift the risk profile.
Vision impact varies: Many nevi never affect vision. If a nevus is near the macula (the central retina) or associated with subretinal fluid or other retinal changes, visual symptoms may occur. Varies by clinician and case in terms of how symptoms are attributed.

choroidal nevus Procedure overview (How it’s applied)

A choroidal nevus is not “applied” as a treatment. Instead, clinicians use a structured evaluation process to identify, document, and monitor it. A typical workflow is:

Evaluation / exam – History review (symptoms, past eye exams, family and medical context). – Dilated eye examination to inspect the retina and choroid. – Assessment of visual acuity and other relevant eye findings.
Preparation – Pupil dilation drops may be used to improve the view of the back of the eye. – Baseline measurements and drawings/notes may be prepared for documentation.
Intervention / testing (diagnostic testing) – Fundus photography to capture an image for comparison over time. – OCT to assess the retina overlying the lesion and look for fluid or structural changes. – Ocular ultrasound (B-scan) when lesion thickness or internal characteristics need assessment, especially if the lesion is elevated. – Other imaging may be considered depending on presentation and resources. Varies by clinician and case.
Immediate checks – Clinician reviews images for features suggesting benign stability versus features that warrant closer monitoring or specialist referral.
Follow-up – A follow-up interval is chosen based on appearance, location, and any concerning features. – Repeat imaging may be used to check for change over time.

Types / variations

Choroidal nevi vary in appearance, location, and associated retinal findings. Clinicians often describe variations using practical categories:

Pigmented vs minimally pigmented (amelanotic)
Pigmented lesions appear gray, brown, or slate-colored.
Amelanotic lesions have less pigment and may be harder to distinguish from other conditions, increasing the importance of imaging.
Flat vs elevated
Many nevi are relatively flat.
Some show measurable elevation; this can influence which imaging tests are used.
Macular vs peripheral location
Macular nevi are nearer central vision and may be more likely to be noticed if they affect the overlying retina.
Peripheral nevi may be entirely asymptomatic and found incidentally.
With or without overlying retinal/RPE changes
Drusen: Small yellowish deposits that can be associated with long-standing lesions.
RPE mottling or atrophy: Pigment changes above the lesion.
Subretinal fluid: Fluid beneath the retina, which may correlate with symptoms and influence monitoring intensity.
Orange pigment (lipofuscin): A description sometimes noted clinically because it can change risk assessment. Interpretation varies by clinician and case.
Solitary vs multiple
Many patients have a single lesion.
Some may have more than one pigmented lesion, which can broaden the differential diagnosis.

Pros and cons

Pros:

Helps clinicians name and categorize a common intraocular finding.
Supports baseline documentation that improves long-term comparisons.
Encourages risk-aware monitoring rather than ignoring an uncertain lesion.
Can prompt appropriate referral when features are atypical or concerning.
Imaging follow-up is generally non-invasive.
May help explain certain retinal findings when symptoms are present (varies by clinician and case).

Cons:

The term can create anxiety because it is sometimes discussed alongside melanoma risk.
Some lesions are difficult to classify on appearance alone, especially if lightly pigmented or poorly visualized.
Monitoring can involve repeat visits and imaging, which may be inconvenient.
Different conditions can mimic a nevus, and additional testing may be required to confirm the diagnosis.
Documentation differences (image angle, lighting, dilation) can make comparisons over time challenging.
There is no “removal” or “cure” implied by the diagnosis; management is often observation, which some patients find unsatisfying.

Aftercare & longevity

Because a choroidal nevus is a long-term finding rather than a temporary treatment, “aftercare” mainly means ongoing eye health follow-up and good-quality documentation.

Factors that affect monitoring and long-term outcomes include:

Baseline lesion features: Size, elevation, proximity to the optic nerve or macula, and associated retinal changes can influence how closely it is followed. Varies by clinician and case.
Quality and consistency of imaging: Comparable photos and scans make it easier to detect meaningful change.
Symptoms and functional impact: New distortion, blur, or scotomas (blind spots) may prompt earlier reassessment, though symptoms can also come from other eye conditions.
Other eye diseases: Coexisting conditions (e.g., macular degeneration, diabetic retinopathy, inflammation) may complicate interpretation of retinal changes overlying the lesion.
Systemic health context: General health factors can influence ocular findings and the differential diagnosis, depending on the case.
Follow-up adherence: Longitudinal comparison is central to management; the timing and frequency of follow-up varies by clinician and case.

In many people, a choroidal nevus remains stable for years, and the main “longevity” concept is whether the lesion’s appearance stays unchanged across repeated exams.

Alternatives / comparisons

Since choroidal nevus is a diagnosis, alternatives are best thought of as other diagnoses or other management pathways that may apply depending on exam findings.

Common comparisons include:

Observation/monitoring vs specialist evaluation
Many lesions are monitored with periodic exams and imaging.
If features are atypical or concerning, clinicians may recommend evaluation by a retinal specialist or ocular oncology service. The threshold for referral varies by clinician and case.
Choroidal nevus vs choroidal melanoma
A nevus is typically benign; melanoma is malignant and may require active treatment.
Distinguishing between them relies on a combination of clinical exam, imaging, and change over time, rather than any single feature in isolation.
Choroidal nevus vs congenital RPE lesions (e.g., CHRPE)
Some dark spots arise from the RPE rather than the choroid.
Location within ocular layers and imaging characteristics help differentiate these.
Choroidal nevus vs choroidal hemangioma
Hemangiomas are vascular lesions and may have different coloration and imaging patterns.
Management focus may differ if fluid or visual symptoms are present.
Choroidal nevus vs scars or inflammatory lesions
Prior inflammation or infection can leave pigmented scars.
History, exam, and imaging are used to determine whether a lesion is a scar versus a nevus.
Non-invasive imaging vs invasive testing
Most evaluation uses photography, OCT, and ultrasound.
Invasive procedures (such as biopsy) are not routine for typical nevi and are generally reserved for select, complex cases. Varies by clinician and case.

choroidal nevus Common questions (FAQ)

Q: Is a choroidal nevus the same as an eye freckle?
A: Many clinicians describe a choroidal nevus as an “eye freckle” because it is a pigmented spot inside the eye. The comparison is helpful, but it is not exact because the lesion is in the choroid beneath the retina. The medical term emphasizes location and tissue layer.

Q: Does a choroidal nevus cause symptoms?
A: Many people have no symptoms, and the lesion is found during a dilated exam. Symptoms can occur if there are changes in the retina above the lesion, such as fluid, or if the lesion is near central vision. Symptoms are not specific and can also be caused by unrelated eye conditions.

Q: How do clinicians confirm it is a choroidal nevus?
A: Confirmation is usually based on a dilated eye exam plus imaging that documents the lesion’s appearance and measurements. Common tools include fundus photography, OCT, and sometimes ultrasound. The diagnosis is often supported by stability over time.

Q: Is the exam or imaging painful?
A: The evaluation is generally non-invasive. Pupil dilation can cause temporary light sensitivity and blur, and bright camera flashes may be uncomfortable for some people. Ultrasound testing uses a probe and gel and is typically well tolerated.

Q: How often does it need to be monitored?
A: Follow-up frequency depends on the lesion’s features, location, and any changes seen on imaging. Clinicians often individualize monitoring schedules based on risk factors and the quality of baseline documentation. Varies by clinician and case.

Q: Can a choroidal nevus turn into cancer?
A: Most choroidal nevi are benign, but clinicians monitor them because a small subset of melanocytic lesions can show suspicious changes over time. Concern is based on clinical features and documented change, not on the presence of a nevus alone. If risk appears higher, additional evaluation may be recommended.

Q: What is the cost range for evaluation and follow-up?
A: Costs vary widely based on region, clinic setting, insurance coverage, and which imaging tests are performed. Follow-up often involves repeat imaging, which can change overall cost. For many patients, the cost range is best discussed with the clinic performing the testing.

Q: Can I drive or use screens after a choroidal nevus exam?
A: The lesion itself does not restrict driving or screen use. However, pupil dilation commonly causes temporary blurry near vision and light sensitivity, which can affect driving comfort and safety until it wears off. Individual experiences vary.

Q: Does a choroidal nevus need to be removed or treated?
A: A typical choroidal nevus is usually managed with observation and documentation rather than removal. Treatment is generally considered only if the diagnosis changes (for example, concern for melanoma) or if associated complications are identified. Management decisions depend on clinical context and specialist assessment.

Q: What does “growth” mean in this context?
A: Growth usually means a measurable increase in lesion size or thickness compared with prior photographs or ultrasound measurements. Clinicians also pay attention to new associated findings, such as fluid or pigment changes, that may alter risk assessment. Interpretation depends on consistent imaging and clinical judgment.